Market Place
Sourcing Support
ProQR Highlights Pipeline Growth and Clinical Milestones
08 Apr 2026 //
GLOBENEWSWIRE
ProQR Forms AI Advisory Board With Ginkgo Bioworks
08 Apr 2026 //
GLOBENEWSWIRE
ProQR to Host Investor-Analyst Pipeline Event April 8, 2026
25 Mar 2026 //
GLOBENEWSWIRE
ProQR Announces Year End 2025 Operating And Financial Results
12 Mar 2026 //
GLOBENEWSWIRE
ProQR Announces AX-0810 Phase 1 Data and 2026 Candidate
08 Jan 2026 //
GLOBENEWSWIRE
Proqr Gets CTA For AX-0810 Plans Investor Event Nov 3, 2025
20 Oct 2025 //
GLOBENEWSWIRE
ProQR to Participate in Upcoming Investor Conferences in Oct 2025
13 Oct 2025 //
GLOBENEWSWIRE
ProQR Announces Upcoming Presentation at RNA Editing Summit
28 Jul 2025 //
GLOBENEWSWIRE
ProQR Submits CTA for Phase 1 Study of AX-0810
26 Jun 2025 //
GLOBENEWSWIRE
ProQR to Present at ASGCT and TIDES Conferences
12 May 2025 //
GLOBENEWSWIRE
ProQR Announces Q1 2025 Results
08 May 2025 //
GLOBENEWSWIRE
ProQR to Webcast Presentation at 2025 Citizens Life Sciences
02 May 2025 //
GLOBENEWSWIRE
ProQR sets Annual General Meeting for June 3, 2025
01 May 2025 //
GLOBENEWSWIRE
ProQR appoints CFO and CMO to support Growth
14 Apr 2025 //
GLOBENEWSWIRE
ProQR Therapeutics Secures $8.1M from Rett Syndrome Research Trust
11 Dec 2024 //
GLOBENEWSWIRE
ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist
10 Dec 2024 //
GLOBENEWSWIRE
ProQR Hosts Virtual Analyst Event on December 11, 2024
05 Dec 2024 //
GLOBENEWSWIRE
ProQR Announces Q3 2024 Operating & Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
ProQR Closes Underwritten Public Offering and Private Placement
25 Oct 2024 //
GLOBENEWSWIRE
ProQR Proposes Underwritten Public Offering Of Shares
22 Oct 2024 //
GLOBENEWSWIRE
ProQR Prices $75M Public Offering And Private Placement
22 Oct 2024 //
GLOBENEWSWIRE
ProQR Highlights Upcoming Presentation At Oligonucleotide Meeting
07 Oct 2024 //
GLOBENEWSWIRE
ProQR Announces Webcast At Cantor Healthcare Conference
10 Sep 2024 //
GLOBENEWSWIRE
ProQR Announces Second Quarter 2024 Operating and Financial Results
08 Aug 2024 //
GLOBENEWSWIRE
ProQR NTCP RNA Editing Data For Cholestatic Diseases
08 May 2024 //
GLOBENEWSWIRE
ProQR Announces Transaction Completed for Théa to Acquire Sepofarsen
08 Dec 2023 //
GLOBENEWSWIRE
ProQR & Laboratoires Théa Announce Agreement to Acquire ProQR’s Sepofarsen
01 Aug 2023 //
GLOBENEWSWIRE
